<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Doo</surname>
    <given-names>NW</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Bortezomib with high dose melphalan conditioning for autologous transplant is safe and effective in patients with heavily pretreated and high risk multiple myeloma</article-title>
  <source>Leuk Lymphoma</source>
  <year>2013</year>
  <volume>54</volume>
  <issue>7</issue>
  <fpage>1465</fpage>
  <lpage>1472</lpage>
  <pub-id pub-id-type="doi">10.3109/10428194.2012.746682</pub-id>
  <?supplied-pmid 23121086?>
  <pub-id pub-id-type="pmid">23121086</pub-id>
 </element-citation>
</ref>
